IASLC Names New Chief Science Officer

Patient Advocate Ivy B. Elkins Leaves Lasting Legacy

Laura Greco of “Die, Cancer, Die!” Fame will be Remembered for her Passionate Patient Advocacy

Pathology Researcher Keith Kerr Receives 2025 Heine H. Hansen Award

Pembrolizumab Considered for Second Tissue-Agnostic Cancer Indication

New FDA Commissioner Confirmed

Dr. Richard Pazdur Discusses Project Facilitate and the Expanded-Access Program

NCI Director Dr. Norman E. Sharpless Discusses 2019 Budget Plans During Social Media Event

FDA Approval Processes in the Era of Targeted Therapies: A Conversation with Dr. Richard Pazdur

NCI Corner: Racial Differences in the Transcriptomes of Lung Tumors

NCI Selects Five Teams of Researchers to Expand Discovery of Predictive Biomarkers for Immunotherapy

The Budget Landscape with Dr. Douglas R. Lowy